VARIZIG
Google image searchProduct monograph
Active ingredient
varicella zoster immunoglobulin (human), 125 UNIT/VIAL
DIN: 02442183
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR, INTRAVENOUS
Description: ALSO KNOWN AS VARICELLA ZOSTER IMMUNE GLOBULIN HUMAN. SINGLE USE VIAL
Schedule: Schedule D
Company: KI BIOPHARMA LLC
Date: 11-JUL-2022
ATC:
- J06 — IMMUNE SERA AND IMMUNOGLOBULINS (ATC, ATC/DDD, )
- J06B — IMMUNOGLOBULINS (ATC, ATC/DDD)
- J06BB — Specific immunoglobulins (ATC, ATC/DDD)
- J06BB03 — VARICELLA/ZOSTER IMMUNOGLOBULIN (ATC/DDD)
Reference brand drug: Varizig